Keytruda (pembrolizumab)

pCPA File Number: 21137
Negotiation Status:
Concluded with an LOI
Indication(s):
Non-Squamous Non-Small Cell Lung Cancer
Sponsor/Manufacturer:
Merck Canada Inc.
CDA-AMC Project Number:
PC0153-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: